Introduction
The study and modeling of the effects of neurotoxicants on brain health is a critical area of research due to the potential adverse impacts on neurological function and development. Various methodologies, including in vitro models, high-content analysis, and risk assessment procedures, are employed to understand and predict the neurotoxic effects of different substances.
Key Insights
-
In Vitro Models for Neurotoxicity Testing:
- Integrated testing strategies (ITS) using in vitro models, including blood-brain barrier (BBB) models and neuronal cell cultures, are effective for evaluating drug-induced neurotoxicity. These models allow for the assessment of drug transport and neuroactivity through metabolomics, proteomics, and electrical activity measurements .
- Multiparametric High Content Analysis (HCA) in differentiated neuronal cell lines and human embryonic stem cell-derived neurons provides robust data on neurotoxic effects, showing significant differences in responses across different cell types.
-
Developmental Neurotoxicity:
- Conventional neuropathology endpoints, such as brain morphology and neuron numbers, are used to assess developmental neurotoxicity. Linear morphometry and stereologic investigations are sensitive methods for detecting changes in brain structure due to neurotoxicants.
- Diverse neurotoxicants, including pesticides and metals, can produce similar effects on neurotrophic factors and their receptors, indicating common pathways of neurodevelopmental disruption.
-
Risk Assessment and Biomarkers:
- Risk assessment for neurotoxic effects often involves estimating risk as a function of dose using bioassay data and biomarkers associated with neurotoxic effects. This approach is more versatile than traditional NOAEL/uncertainty factor methods .
- Experience-dependent neuroanatomical plasticity is a sensitive biomarker for detecting subtle neurotoxic damage in developing brains, often at doses lower than those affecting cortical morphogenesis.
-
Specific Neurotoxicants:
- Hexavalent chromium [Cr(VI)] is recognized as a neurotoxicant affecting mitotic cells in the brain, leading to oxidative damage, neurodegeneration, and behavioral changes. However, its link to brain cancers remains inconclusive.
Conclusion
The study and modeling of neurotoxicants involve a combination of in vitro models, high-content analysis, and risk assessment procedures. These methods provide comprehensive insights into the neurotoxic effects of various substances, particularly in developmental contexts. Integrated testing strategies and sensitive biomarkers, such as experience-dependent plasticity, enhance the detection and understanding of neurotoxic damage, contributing to more effective risk assessment and regulatory measures.